Home Bromides 259808-63-4
259808-63-4,MFCD09746327
Catalog No.:AA002R7X

259808-63-4 | 4-(4-BOC-piperazinosulfonyl)bromobenzene

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$25.00   $18.00
- +
5g
98%
in stock  
$74.00   $52.00
- +
25g
98%
in stock  
$292.00   $205.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA002R7X
Chemical Name:
4-(4-BOC-piperazinosulfonyl)bromobenzene
CAS Number:
259808-63-4
Molecular Formula:
C15H21BrN2O4S
Molecular Weight:
405.3072
MDL Number:
MFCD09746327
SMILES:
O=C(N1CCN(CC1)S(=O)(=O)c1ccc(cc1)Br)OC(C)(C)C
Properties
Properties
 
Form:
Solid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
511  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
5  
Rotatable Bond Count:
4  
XLogP3:
2.4  

Downstream Synthesis Route

[1]LeManach,Claire;Paquet,Tanya;GonzàlezCabrera,Diego;Younis,Yassir;Taylor,Dale;Wiesner,Lubbe;Lawrence,Nina;Schwager,Sylva;Waterson,David;Witty,MichaelJ.;Wittlin,Sergio;Street,LeslieJ.;Chibale,Kelly[JournalofMedicinalChemistry,2014,vol.57,#21,p.8839-8848]

[2]GaddaleDevanna,KishoreK.;Gawel,JustynaM.;Prime,TracyA.;Cvetko,Filip;Benincá,Cristiane;Caldwell,StuartT.;Negoda,Alexander;Harrison,Andrew;James,AndrewM.;Pavlov,EvgenyV.;Murphy,MichaelP.;Hartley,RichardC.[ChemicalCommunications,2021,vol.57,#25,p.3147-3150]

[3]Nguyen,William;Dans,MadelineG.;Ngo,Anna;Gancheva,MariaR.;Romeo,Ornella;Duffy,Sandra;deKoning-Ward,TaniaF.;Lowes,KymN.;Sabroux,HeleneJousset;Avery,VickyM.;Wilson,DannyW.;Gilson,PaulR.;Sleebs,BradE.[EuropeanJournalofMedicinalChemistry,2021,vol.214]

[4]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN113248473,2021,ALocationinpatent:Paragraph0092;0112;0116-0118

[5]Qu,Lailiang;Li,Shang;Ji,Limei;Luo,Si;Ding,Ming;Yin,Fucheng;Wang,Cheng;Luo,Heng;Lu,Dehua;Liu,Xingchen;Peng,Wan;Kong,Lingyi;Wang,Xiaobing[EuropeanJournalofMedicinalChemistry,2021,vol.226]

[6]Yu,Jinha;Ciancetta,Antonella;Dudas,Steven;Duca,Sierra;Lottermoser,Justine;Jacobson,KennethA.[JournalofMedicinalChemistry,2018,vol.61,#11,p.4860-4882]

[7]CurrentPatentAssignee:SANOFI-US2005/245524,2005,A1Locationinpatent:Page/Pagecolumn54

[8]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2010/55005,2010,A1Locationinpatent:Page/Pagecolumn120

[9]CurrentPatentAssignee:VERTEXPHARMACEUTICALS(OLD)-WO2004/111014,2004,A1Locationinpatent:Page/Pagecolumn263

[10]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-US2019/192668,2019,A1Locationinpatent:Paragraph2524;2525

[11]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/10210,2020,A1Locationinpatent:Paragraph00687;00944

[12]CurrentPatentAssignee:ASTRAZENECAPLC-WO2007/40440,2007,A1Locationinpatent:Page/Pagecolumn86-87

[13]CurrentPatentAssignee:PALAUPHARMASA-WO2008/90181,2008,A1Locationinpatent:Page/Pagecolumn64

[14]CurrentPatentAssignee:DAIICHISANKYOCOMPANY,LIMITED-EP1104754,2001,A1

[15]CurrentPatentAssignee:SANOFI-WO2006/101977,2006,A2Locationinpatent:Page/Pagecolumn99

[16]Berrade,Luis;Aisa,Bárbara;Ramirez,MaríaJ.;Galiano,Silvia;Guccione,Salvatore;Moltzau,LiseRomán;Levy,FinnOlav;Nicoletti,Ferdinando;Battaglia,Giuseppe;Molinaro,Gemma;Aldana,Ignacio;Monge,Antonio;Perez-Silanes,Silvia[JournalofMedicinalChemistry,2011,vol.54,#8,p.3086-3090]

[17]CurrentPatentAssignee:C.H.BoehringerSohnAG&Co.KG-US2018/44335,2018,A1Locationinpatent:Paragraph0895-0896

[18]Jiang,Donghao;Chen,Jixiang;Zan,Ningning;Li,Chunyi;Hu,Deyu;Song,Baoan[JournalofAgriculturalandFoodChemistry,2021,vol.69,#41,p.12126-12134]

[1]Patent:WO2006/101977,2006,A2.Locationinpatent:Page/Pagecolumn99

[1]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2020/10210,2020,A1Locationinpatent:Paragraph00688;00945

[2]LeManach,Claire;Paquet,Tanya;GonzàlezCabrera,Diego;Younis,Yassir;Taylor,Dale;Wiesner,Lubbe;Lawrence,Nina;Schwager,Sylva;Waterson,David;Witty,MichaelJ.;Wittlin,Sergio;Street,LeslieJ.;Chibale,Kelly[JournalofMedicinalChemistry,2014,vol.57,#21,p.8839-8848]

[3]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-US2019/192668,2019,A1Locationinpatent:Paragraph2524;2526

[1]CurrentPatentAssignee:CHINAPHARMACEUTICALUNIVERSITY-CN113248473,2021,ALocationinpatent:Paragraph0092;0112;0119-0121

[2]Qu,Lailiang;Li,Shang;Ji,Limei;Luo,Si;Ding,Ming;Yin,Fucheng;Wang,Cheng;Luo,Heng;Lu,Dehua;Liu,Xingchen;Peng,Wan;Kong,Lingyi;Wang,Xiaobing[EuropeanJournalofMedicinalChemistry,2021,vol.226]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:259808-63-4 Molecular Formula|259808-63-4 MDL|259808-63-4 SMILES|259808-63-4 4-(4-BOC-piperazinosulfonyl)bromobenzene